Snapshot from Sep 18, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical research

Finasteride linked to fewer heart attack complications

Analysis based on 8 articles · First reported Aug 26, 2026 · Last updated Aug 29, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study may modestly boost interest in finasteride's potential cardioprotective effects, but it is observational and not expected to change clinical practice or significantly affect drug sales. Pharmaceutical companies with finasteride products could see minor positive sentiment, while the broader market impact is limited.

Pharmaceuticals Healthcare

A registry study from the University of Gothenburg, published in JAMA Network Open, found that men taking finasteride for benign prostatic hyperplasia at the time of a severe ST-elevation myocardial infarction (STEMI) treated with balloon angioplasty had a lower risk of serious complications. Among finasteride users, 20.8% experienced serious complications (cardiac arrest, severe arrhythmias, severely impaired left ventricular function, or death within 30 days) versus 24.3% in matched controls. The study used data from the SWEDEHEART registry and national registers. The researchers caution that the finding is observational and does not currently support using finasteride as a heart attack treatment. No significant association was seen with hormone therapy for prostate cancer.

oth
Provided the registry data that enabled the study, demonstrating its value as a research resource.
Importance 70.0 Sentiment 5.0
per
First author and spokesperson, gaining professional recognition.
Importance 60.0 Sentiment 5.0
per
Senior author, contributing to the research and its credibility.
Importance 60.0 Sentiment 5.0
cnt
The study used Swedish health data, highlighting the country's healthcare research infrastructure.
Importance 40.0 Sentiment 5.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.